![logo](/logos/KOPRAN.NS.webp)
Kopran Limited
NSE:KOPRAN.NS
335.5 (INR) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Kopran Limited |
Symbool | KOPRAN.NS |
Munteenheid | INR |
Prijs | 335.5 |
Beurswaarde | 16,174,656,300 |
Dividendpercentage | 1.2% |
52-weken bereik | 185.45 - 346.95 |
Industrie | Drug Manufacturers—General |
Sector | Healthcare |
CEO | Mr. Surendra Shrikrishna Somani B.Com. |
Website | https://www.kopran.com |
An error occurred while fetching data.
Over Kopran Limited
Kopran Limited, an integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, dry powder, suspension, and injectables. It also provides active pharmaceutical ingredients in the categories of macrolide, antibacterial, anticonvulsant,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)